mTOR Inhibitors as Radiosensitizers in Neuroendocrine Neoplasms.

Exner, Samantha; Arrey, Gerard; Prasad, Vikas; Grötzinger, Carsten

Exner, Samantha; Arrey, Gerard; Prasad, Vikas; Grötzinger, Carsten.

Afiliação

Exner S; Department of Hepatology and Gastroenterology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Arrey G; Department of Hepatology and Gastroenterology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Prasad V; Department of Nuclear Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Grötzinger C; Department of Nuclear Medicine, University Hospital Ulm, Ulm, Germany.

Front Oncol ; 10: 578380, 2020.

Article em En | MEDLINE | ID: mdl-33628728

Palavras-chave

mTOR inhibitors; neuroendocrine neoplasms; peptide receptor radioligand therapy; radiosensitizer; signaling

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google